News

Cambrex, a provider of products and services to accelerate the development and commercialization of small molecule therapeutics, has reported increase in net income to $4.7m in the first

SOCMA and partners in federal government are working together to bring the latest information and guidance with regards to swine flu out break in the US and Mexico.

The cooperative R&D agreement (CRADA) is for a two-year study that will utilize the Biojector 2000 in human subjects. An additional objective is to promote a partnering relationship

The Prescription Drug User Fee Act date is the target date for the FDA to complete its review of the Fampridine-SR new drug application (NDA). Ron Cohen, president

According to Novagali Pharma, Catioprost is a topical ocular proprietary BAK-free formulation of latanoprost which furthermore benefits from the ocular surface protection properties of Novasorb, its patented technology

Under the commercial agreement, the Consortium will explore production of MVA85A using the ProBioGen AGE1.CR.pIXA cell line, which was developed to replace chicken embryonic fibroblasts and chicken eggs

Under the commercial agreement, the Consortium will explore production of MVA85A using the Vivalis EB66 cell line, which is derived from duck embryonic stem cells. This cell line

Initially Ocimum will service gene expression studies on the Affymetrix platform from its facility at IJsselstein, The Netherlands. Within a couple of months, it will launch the entire

As president of Takeda Global R&D, Center, US, Dr Nabulsi directs all aspects of Takeda’s US drug development activities, including the identification of new product candidates, execution of